AbCellera Biologics Inc. (ABCL)

ABCL trades at $5.9, 47.5% above the near-term max pain of $4 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($3-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 4 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ABCL shows an upward trend from 3 to 5, suggesting bullish positioning in longer-dated options. The 52% spread signals divergent expectations across timeframes. Most levels below 5.9 may cap rallies. Strong magnetic level at 4 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.